Reports from Duke Cancer Institute Highlight Recent Findings in Prostate Cancer (Real-world Overall Survival With Abiraterone Acetate Versus Enzalutamide In Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer)

Source :: Cancer Weekly. April 30, 2024, 63
Publication Year :: 2024
Abstract: 2024 APR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Prostate Cancer have been presented. According to news reporting from [...]

Subjects :: Analysis
Patient outcomes
Enzalutamide -- Analysis
Chemotherapy -- Analysis
Abiraterone -- Analysis
Prostate cancer -- Patient outcomes
Cancer metastasis -- Patient outcomes
Acetates -- Analysis
Metastasis -- Patient outcomes
Cancer -- Chemotherapy

Tools